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Abstract
DYT1 dystonia is caused by mutation of the TOR1A gene, resulting in the loss of a single glutamic acid residue near the
carboxyl terminal of TorsinA. The neuronal functions perturbed by TorsinA[DE] are a major unresolved issue in
understanding the pathophysiology of dystonia, presenting a critical roadblock to developing effective treatments. We
identified and characterized the zebrafish homologue of TOR1A, as a first step towards elucidating the functions of TorsinA
in neurons, in vivo, using the genetically-manipulable zebrafish model. The zebrafish genome was found to contain a single
alternatively-spliced tor1 gene, derived from a common ancestral locus shared with the dual TOR1A and TOR1B paralogues
found in tertrapods. tor1 was expressed ubiquitously during early embryonic development and in multiple adult tissues,
including the CNS. The 2.1 kb tor1 mRNA encodes Torsin1, which is 59% identical and 78% homologous to human TorsinA.
Torsin1 was expressed as major 45 kDa and minor 47 kDa glycoproteins, within the cytoplasm of neurons and neuropil
throughout the CNS. Similar to previous findings relating to human TorsinA, mutations of the ATP hydrolysis domain of
Torsin1 resulted in relocalization of the protein in cultured cells from the endoplasmic reticulum to the nuclear envelope.
Zebrafish embryos lacking tor1 during early development did not show impaired viability, overt morphological
abnormalities, alterations in motor behavior, or developmental defects in the dopaminergic system. Torsin1 is thus non-
essential for early development of the motor system, suggesting that important CNS functions may occur later in
development, consistent with the critical time window in late childhood when dystonia symptoms usually emerge in DYT1
patients. The similarities between Torsin1 and human TorsinA in domain organization, expression pattern, and cellular
localization suggest that the zebrafish will provide a useful model to understand the neuronal functions of Torsins in vivo.
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Introduction
Dystonia is characterized by sustained, patterned involuntary
muscle contractions resulting in abnormal postures and twisting
movements [1]. The most common form of hereditary dystonia is
linked to the DYT1 locus; initial clinical manifestations of DYT1
dystonia usually occur during late childhood and adolescence [2].
DYT1dystonia is causedbymutations in theTOR1Agene encoding
TorsinA [3]. Nearly all patients harbor an in-frame trinucleotide
GAG deletion in exon 5 of TOR1A, resulting in the loss of a single
glutamic acid (DE) near the carboxyl terminal of TorsinA. The
mutant allele gives rise to dystonia that is inherited as an autosomal
dominant trait. Only approximately 40% of mutation carriers
manifestdystonia[2].Thereasons for this reducedpenetrancearenot
known; several hypotheses havebeen suggested, includingmodifying
genes and environmental stressors [4].
TorsinA is a member of the AAA+ superfamily of proteins
(ATPase associated with various cellular activities). Torsins are
found only in metazoan animals, and a unique subset has arisen in
the vertebrate lineage [4]. Members of the AAA+ family have roles
in a diverse array of cellular functions [5]. In vitro studies have
implicated human TorsinA in numerous cellular processes
including cytoskeletal dynamics [6], synaptic vesicle cycling [7]
and the secretory pathway [8,9]. TorsinA is expressed in a wide
variety of cell types [10] and colocalizes predominately with
endoplasmic reticulum (ER) markers [11]. Mutant TorsinA[DE]
shows aberrant cellular localization, being redistributed from the
ER to the nuclear envelope (NE) in some cell lines [12], and
forming cytoplasmic membranous whorls in others [11]. Similar to
mutant TorsinA[DE], disruption of the Walker B ATP hydrolysis
domain of TorsinA by mutagenesis also resulted in relocalization
to the NE [9,12]. Because comparable Walker B domain
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mutations in other AAA+ family members exhibit stabilization of
substrate interactions [13,14], the similar redistribution of TorsinA
by ATP hydrolysis domain and DE mutations led to the hypothesis
that both mutations prevent disengagement of TorsinA from a NE
resident protein [15]. However, accumulating data suggest that the
ATP hydrolysis domain and DE mutants may not be mechanis-
tically equivalent; the two mutants differ in the formation of
membranous whorls [15] and in the strength of co-immunopre-
cipitation with two putative NE substrates [16].
Although these studies have started to elucidate the cellular
functions of Torsins, the mechanisms by which mutant Torsi-
nA[DE] causes dystonia are not understood. Despite the dramatic
clinical abnormalities, brain tissue from DYT1 dystonia patients is
histopathologically unremarkable at autopsy, suggesting that
aberrant activity or connectivity in neural circuits might underlie
the pathophysiology of dystonia [17]. Consequently, there has
been significant interest in generating model systems to gain
insights into the functions of TorsinA in neurons and motor
circuits in vivo. In C. elegans, mutations in the Torsin-related ooc-5
gene disrupted spindle orientation and PAR protein polarity at the
2-cell stage of development, thereby preventing asymmetric
divisions and cell fate determination [18]. The D. melanogastor
genome contains a single Torsin family member, dtorsin. Knock-
down of dtorsin in the retina by RNA interference altered the
cellular organization of pigment granules, suggesting a role in
intracellular transport [19]. Analysis of dtorsin2/2 mutants suggested
that dtorsin may act as a positive regulator of GTP cyclohydrolase,
an enzyme important in the production of BH4, a limiting cofactor
in dopamine synthesis [20]. In mice, multiple strategies have been
employed to generate a transgenic model of dystonia. Although
these models have yielded insights into the neuronal mechanisms
perturbed by expression of TorsinA[DE], none of these models
exhibits clinical dystonia [21–27]. Inactivation of endogenous
murine TOR1A by homologous recombination caused perinatal
lethality, despite the absence of overt developmental morpholog-
ical abnormalities. Transgenic mice overexpressing human
TorsinA[DE] under the immediate-early promoter from cytomeg-
alovirus (CMV) did not develop dystonia, although a deficit in
motor learning was identified [25], as well as a reduced response to
amphetamine [28] and changes in the bidirectional plasticity of
glutamatergic synapses between cortical neurons and striatal
medium spiny neurons [29]. Although these results confirm an
important role for TorsinA in motor control, the current strategies
have not resulted in a model that would allow physiological,
pharmacological and molecular studies to understand the patho-
physiology of dystonia and develop treatments for this condition.
There has been increasing interest in the use of zebrafish models
to provide novel insights into mechanisms of human disease [30],
and a zebrafish model of DYT1 dystonia could be very useful.
Zebrafish can be manipulated to be transparent during larval
development, allowing the deployment of fluorescent reporter
proteins and chemical probes to monitor activity in neural circuits
[31], dynamic changes in gene expression [32] and cellular
movement and morphology in vivo [33]. Zebrafish can be
genetically modified using simple and widely available methods,
allowing hypotheses concerning molecular mechanisms to be
tested rapidly. Since zebrafish produce large clutches of embryos,
screens for genetic modifiers are feasible. In addition, the ability to
house zebrafish larvae in 96-well plates facilitates exposure to
chemical libraries, permitting discovery of small molecule modi-
fiers and candidate novel therapeutic agents [34]. With specific
relevance to dystonia models, the availability of automated
neurobehavioral assays would allow high-throughput chemical or
genetic screens to be driven by phenotypic abnormalities relevant
to the function of motor circuits [35]. Finally, the zebrafish
presents an accessible vertebrate model for neurophysiological
studies to determine the effects of genetic manipulations on the
function of motor systems [36,37]. Zebrafish models have recently
been used to study several other movement disorders, including
Parkinson’s disease [38,39], Huntington’s disease [40], and ataxias
[41]. The high degree of phylogenetic conservation of genes and
molecular pathways relevant to disease pathogenesis, and the
many neurochemical and neuroanatomical similarities shared
between vertebrates of different classes [42,43], suggests that
insights yielded by zebrafish models will be applicable to human
disease.
As a first step towards generating a zebrafish model of DYT1
dystonia, we identified the zebrafish homolog of TorsinA. Here,
we show that the zebrafish genome contains a single tor1 gene,
expressed as two splice variants, in contrast to the dual TOR1A
and TOR1B paralogues found in tetrapod genomes. Zebrafish
Torsin1 shares a similar protein domain structure with human
TorsinA; like its human homologue mutations in the ATP
hydrolysis domain of Torsin1 resulted in redistribution of the
protein to the nuclear envelope. Similar to murine TOR1A, loss of
tor1 during early development did not cause morphological defects
in the nervous system, loss of dopamine neurons or deficits in
spontaneous movement. Taken together, our findings provide an
essential basis for further studies to elucidate the functions of
Torsin proteins in CNS function and for future development of a
zebrafish DYT1 dystonia model.
Methods
Ethics Statement
All studies were carried out in accordance with NIH guidelines
for animal care and use, and with approvals from the University of
Pittsburgh Institutional Animal Care and Use Committee.
Zebrafish
Adult strain AB zebrafish were maintained at 28.5uC and
euthanized by deep tricaine anesthesia followed by exposure to
ice-cold water. Embryos were raised in E3 buffer (5 mM NaCl,
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) supplement-
ed, where necessary, with 0.003% 1-phenyl 2-thiourea (PTU) to
inhibit pigmentation.
RT-PCR and Rapid Amplification of cDNA Ends (RACE)
RT-PCR and RACE were carried out as previously described
[44–46]. Briefly, total RNA was extracted from adult Zebrafish
brain (RNAqueous, Ambion, Austin, TX) and reverse transcribed
(SuperScript III, Invitrogen, Carlsbad, CA) using oligo-dT or
39RACE adapter primers (FirstChoice RACE, Ambion, Austin,
TX). For 59RACE, RNA was treated with tobacco acid
pyrophosphatase and RACE adapter was ligated prior to reverse
transcription. Zebrafish tor1 was amplified by RACE using adapter
primers and gene-specific primers (59 RACE: 59-GGCTTTCAG-
GATGACTTGACCT-39; 39 RACE: 59-
TTCAGGTGGCTCTGGATTTC-39) and by RT-PCR using a
pair of gene-specific primers (tv1F=59-CGGAAGTGGGTCGT-
CATTAT-39; tv2F=59-CCACCCTGTTTCCGACTAAA-39;
ex5R: 59-CCCTTTAAAACAGGGACACG-39). bactin1 was am-
plified as a control (bactin1F: 59-CCAACTGGGATGATATG-
GAGAAGA-39; bactin1R: 59-CAATGGTGAT-
GACCTGTCCGTC-39). PCR products were cloned in pGEM-
T (Promega, Madison, WI) and sequenced. Expression vectors for
Torsin1-GFP fusion proteins were generated by inserting the
coding sequence of tor1 in frame into pCS2+eGFP, resulting in the
Zebrafish tor1
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fusion of GFP to the C-terminus of Torsin1. Mutations were
introduced into the coding sequence of the Torsin1a-eGFP fusion
construct by site-directed mutagenesis (QuikChange, Stratagene, La
Jolla, CA).
Northern Blot
Northern blots were carried out as previously described [44,46].
Briefly, total RNA, extracted from adult zebrafish brain (RNAqu-
eous, Ambion, Austin, TX), was electrophoretically separated in a
1% agarose fomaldehyde/MOPS gel, and transferred to a Nytran-
N membrane (Schleicher and Schuell BioScience, Keene, NH).
Labeled tor1 antisense probe was generated by in vitro transcription
with UTP-digoxigenin (Roche, Indianapolis, IN). Membrane was
hybridized in Ultra-Hyb (Ambion, Austin, TX) containing Torula
RNA (1 mg/mL; Sigma, St. Louis, MO) and labeled cRNA probe
(25 ng/mL) at 68uC. Stringency washes were carried out in 0.16
SSC/0.1% SDS at 68uC. Probe was detected using anti-DIG
antibody conjugated to alkaline phosphatase (Roche, Indianapolis,
IN) with a light-emitting AP substrate (CDP-star, Roche, India-
napolis, IN).
Whole Mount RNA in situ Hybridization
In situ hybridization was carried out as previously described
[44,46]. Briefly, embryos were fixed in 4% paraformaldyde
overnight at 4uC. After washing in PBS, embryos were dehydrated
with methanol and stored at 220uC. Embryos were next washed
in acetone at220uC, hydrated with 50%, 30% methanol and then
washed in PBS. Permeabilization with Protease-K (10 mg/mL) was
followed by post-fixing in 4% PFA and washing in PBTw (PBS,
0.1% Tween, 0.2% BSA). Embryos were incubated in UltraHyb
Buffer (Ambion) containing 1 mg/mL, Torula RNA, 50 mg/mL
heparin and 150 ng/mL cRNA probe. Washes were carried out in
50% formamide, 26 SSC, 0.3% CHAPS, then 26 SSC, 0.3%
CHAPS, followed by 0.26 SSC, 0.3% CHAPS. Blocking in 16
maleic acid buffer pH7.4, 1% blocking agent (Roche, Indianapolis,
IN), was followed by incubation in alkaline phosphatase conju-
gated anti-DIG antibody at 37uC. After washing in PBS, antibody
hybridization was detected with BM Purple (Roche, Indianapolis,
IN).
Torsin1 Antibody and Western Blots
Torsin1 antibody was generated by inoculating rabbits with the
peptide CPDKEVVEKMAHD derived from the C-terminus of
Torsin1, linked at its N terminus to keyhole limpet hemacyanin
(New England Peptide). Crude antiserum was affinity purified
against the peptide using a column (SulfoLink, Pierce, Rockford, IL)
as previously described [47]. Transfected cells or adult zebrafish
brains were sonicated in RIPA buffer (10 mM Tris, 150 mM
NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, and 1%
sodium deoxycholate, pH7.4) and protein concentrations were
measured using BCA assay. Equal amounts of protein were
resolved on a 10% polyacrylamide gel, transferred to nitrocellu-
lose, and blocked with 10% milk in TBS (50 mM Tris-HCl,
150 mM NaCl, 0.2% Tween-20). Torsin1 affinity-purified anti-
body was used at a concentration of 1:1000, and was detected
using HRP-conjugated proteinA (1:4000; GE Healthcare, Piscat-
away, NJ). For peptide competition experiments, Torsin1 antibody
was pre-incubated with 760 mM peptide in PBS for 2.5 hours at
37uC.
Immunohistochemistry
Adult zebrafish brains were fixed in 4% PFA and cryoprotected
in a sucrose series. 14 mm cryosections were incubated with
Torsin1 antibody (1:500) in carrier buffer (PBS, 1% goat serum,
1% BSA). Primary antibody was detected using an anti-rabbit
HRP-conjugated antibody (1:1000; Pierce, Rockford, IL) and a
chromogenic histochemical reaction (NovaRed, Vector Laborato-
ries, Burlingame, CA). Sections were counter-stained with Mayer’s
hematoxylin (Sigma, St. Louis, MO).
Cell Culture
HEK cells were maintained in DMEM supplemented with 10%
FBS and 50 mg/mL of each penicillin and streptomycin and
maintained at 37uC in a humidified, 5% CO2 incubator. MN9D
cells [48] (a gift from Dr. Alfred Heller, University of Chicago)
were maintained in DMEM high glucose, supplemented with 10%
FBS and 50 mg/mL of each penicillin and streptomycin and
maintained at 37uC in a humidified, 5% CO2 incubator. Cells
were grown to 80% confluence and transfected with 2 mg plasmid
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). The
following day, cells were transferred to Poly-D coated glass
coverslips and allowed to adhere overnight. Cells were fixed in 4%
PFA, washed in 1X PBS, counterstained with DAPI and mounted
to slides for imaging.
Morpholino Knockdown of tor1
To examine the function of tor1 during development we
employed morpholino oligonucelotides (MOs) to target tor1
expression. MOs bind complementary nucleic acid sequences
with high affinity, allowing sequence-specific inhibition of splicing
or translation by targeting splice consensus sequences in pre-
mRNA or the translational initiation sequences of mRNAs [49].
6 ng each of two different tor1 splice-blocking MOs (exon2/intron2:
59-ATATGAAGTCAGCTTACCTTGTAGG-39; exon3/intron3:
59-TGTTAGTAGACACTGACCTGAGGAA-39) or two differ-
ent controls (standard: 59-CCTCTTACCTCAGTTACAATT-
TATA-39; random: 59-(N)25-39) were diluted in 2 nL 16Danieau
buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM
Ca(NO3 )2, 5.0 mM HEPES, pH 7.6) and injected into single cell
embryos. Embryos were mechanically dechorionated at 24 hours
post-fertilization (hpf) and raised at 28.5uC on a 14:10 light:dark
cycle for subsequent behavioral experiments.
Spontaneous Movement Assays
Spontaneous movement was measured at 5 dpf as previously
described [50,51]. Embryos (at least 16 per group) were
transferred to individual wells of a 96-well plate. Spontaneous
movement was recorded using a video camera, and the resulting
video files were analyzed using custom MatlabH algorithms [50] to
determine: mean velocity (total displacement/total time of
recording); active velocity (total displacement/time spent moving);
% time moving (time spent moving/total time of recording); mean
rest duration and mean duration of active episodes. All data sets
were analyzed by both parametric (ANOVA) and non-parametric
(Kruskal-Wallis) tests. Most of the data sets at this age point were
normally distributed as evaluated by D’Agostino & Pearson’s test.
For clarity, raw data are shown along with mean and standard
error.
Results
Identification of a Zebrafish TorsinA Homologue
To identify zebrafish proteins with homology to human
TorsinA, the zebrafish RefSeq and non RefSeq mRNA databases
(www.ncbi.nlm.nih.gov; final accession date: August, 11, 2011)
were interrogated by TBLASTN using the human TorsinA
protein sequence as a probe. Eight sequences (six transcripts and
Zebrafish tor1
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two predicted transcripts) with homology to human TorsinA were
further analyzed. The predicted translations of the zebrafish
sequences were aligned with Torsin protein sequences derived
from human, chicken and xenopus, as well as the nearest C. elegans
and drosophila homologs, using the ClustalX 2.1 algorithm, [52],
and a dendrogram was constructed to illustrate the inferred
evolutionary relationships between the proteins, using the BEAST
program [53] (figure 1). Two putative zebrafish proteins appeared
most closely related to Torsin1 family proteins from other
vertebrate species. Putative zebrafish orthologues of mammalian
Torsin2 and Torsin3 family proteins were also detected.
Comparison of the mRNA and genomic sequences for the two
putative zebrafish Torsin1 proteins showed that the two transcripts
are derived from a single gene by inclusion of alternative 59 exons
(figure 2). We refer to the gene (si:ch73-178d14.1) as tor1, and its
two transcript variants as tor1_tv1 (NM_001200015) and tor1_tv2
(BC_050957). The resulting proteins are referred to as Torsin1a
and Torsin1b respectively. The tor1 gene maps to zebrafish
chromosome 21, and spans approximately 11.78 kb of sequence.
An expressed sequence tag (EST; AA542632) encoding amino
acids 14–140 of Torsin1a was previously reported as TOR1C [54].
The zebrafish genome also contains an additional cluster of four
adjacent genes on chromosome 23 predicted to encode Torsin-like
proteins. Sequence comparison suggests that these putative
proteins are most closely related to Torsin1 and Torsin3 family
proteins, although they show less homology than either Torsin1a
or Torsin1b to human TorsinA. We found evidence that two of
these genes (NP_001124104 and NP_957150) are transcribed.
Each of these genes shows divergent exon structure with respect to
human TOR1A, suggesting that they are more distantly related
than tor1 to TOR1A (see below). The Torsin-like gene cluster was
not found in other teleosts and was located in a region of
chromosome 23 with little conservation of synteny with respect to
other teleosts (not shown).
In order to better understand the relationships between
zebrafish and human Torsins, we next examined the genomic
context of Torsin1 family genes in the human, and how this is
conserved in other vertebrate species (figure 3). In human, the dual
torsin1 family members TOR1A and TOR1B are adjacent and
inverted with respect to one another. The order of the flanking
genes PRRX2– PTGES – TOR1A – TOR1B – C9orf78–
USP20– FNBP1 is conserved from mammals to amphibians
(figure 3A). In coelacanth, a later diverging fish species, this gene
order is also conserved. However, similar to other fish species,
coelacanth has a single tor1 gene instead of the dual TOR1A and
TOR1B genes found in xenopus and human. This suggests that
tor1 was duplicated at the root of the tetrapod lineage.
In earlier diverging fish species (figure 3B), substantial genomic
rearrangements with respect to tetrapods and coelacanth disrupt
the conservation of synteny surrounding the Torsin1 family genes.
fnbp1 is found in close proximity to tor1 in fugu, stickleback and
tetraodon, but is located <2 MB upstream of tor1 in the zebrafish
genome. Interestingly, the genes immediately flanking TOR1A
and TOR1B in human are found in syntenic blocks separated
from tor1 in earlier-diverging fish species. Thus ptges and usp20 are
adjacent to one another, but located .350 kb from tor1, in fugu,
stickleback and teraodon; in zebrafish, these genes and c9orf78 are
located on a different chromosome to tor1. However, tor1 otherwise
shows conserved syntenic relationships in all four fish species.
Given the proximity of tor1 and fnbp1 in three of the species, and
the single tor1 gene in coelacanth despite conservation of synteny
with human a TOR1A and TOR1B, these data are consistent
with the other findings reported here suggesting that zebrafish tor1
and human TOR1A and TOR1B may share a common genomic
origin.
tor1 Transcriptional Start Sites, Full cDNA Sequences,
Transcript and Genomic Organization
We cloned zebrafish tor1 cDNA and mapped its transcriptional
start sites by rapid amplification of cDNA ends (RACE), using
RNA isolated from adult zebrafish brain tissue. 59RACE was
carried out using the tobacco acid pyrophosphatase (TAP) method
to allow specific ligation of the RACE adapter to the 59 end of
mRNA transcripts (figure 4A). tor1 cDNA was amplified using a 39
primer complementary to exon 2 of the tor1 mRNA (which is
shared by both transcript variants) and a 59 RACE adaptor
primer, yielding a single PCR product. TAP2 controls confirmed
that amplification of this product was dependent on hydrolysis of
the 7-methylguanylate mRNA cap prior to adapter ligation; RT-
PCR controls confirmed that reverse transcription was equivalent
in both TAP2 and TAP+ samples. These controls show that the
boundary between the RACE adapter and the cDNA sequence
corresponds to the 59 end of the transcript and hence the
transcriptional start site in the genomic sequence. 59RACE
products were cloned and sequenced: tor1_tv1 and tor1_tv2 were
found to initiate transcription from different promoters located at
the 59 end of the gene; the unique first exons in each transcript
splice into a common mRNA at exon 2 (figure 2). A single major
transcriptional start site was found in tor1_tv1, whereas tor1_tv2
showed two different 59 termini (figure 4B, C). As is commonly
found in ubiquitously-expressed genes, neither promoter region
contained a consensus TATA box or initiator motif [55].
The 39 end of the tor1 transcript was cloned by 39RACE
(figure 4D). A single polyadenylation signal (GATAAA) was
located at position 1862 with respect to the first nucleotide of
tor1_tv1. This poly(A) signal is located 24 bp upstream of the
poly(A) tail, and is shared by both transcript variants. After
allowing for addition of the poly(A) tail, the sizes of the complete
tor1_tv1 (1881 bp) and tor1_tv2 (1886 bp) cDNA sequences are
compatible with the single <2.1 kb tor1-hybridizing band found
on northern blot analysis of brain RNA (figure 4E).
The tor1 cDNA sequences were next mapped to the Zv9
assembly of the zebrafish genomic sequence and the exon
boundaries and splice sites determined (figure 5). Both zebrafish
tor1 and human TOR1A transcripts contain 5 exons. The phases
of all splice boundaries are conserved between TOR1A and tor1.
In addition, exons 2, 3, and 4, which encode the majority of the
open reading frame, share identical lengths between the human
and zebrafish sequences. This striking conservation of genomic
organization between the human TOR1A and zebrafish tor1 genes
provides further evidence that they descend from a common
ancestral gene.
Expression of tor1 in Zebrafish
We next determined the temporal and spatial expression
patterns of tor1. mRNA for both tv1 and tv2 was detected by
RT-PCR during early embryonic development (not shown).
However, isoform-specific probes complementary to the short
exon sequences unique to each transcript yielded insufficient signal
in whole mount RNA in situ hybridization assays to localize tor1
transcripts. Consequently, we employed a larger cRNA probe
complementary to the entire tor1 open reading frame (ORF)
shared by both transcripts. This tor1 ORF cRNA probe specifically
detects a single tor1 transcript on Northern blot (figure 4E) and
shares less than 60% sequence identity with the closest related
gene; consequently, the probe is expected to hybridize specifically
with tor1 transcripts under the high stringency conditions used for
Zebrafish tor1
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RNA in situ hybridization. At 12 hours post fertilization (hpf), tor1
was expressed throughout the embryo (figure 6A). A sense control
probe did not show hybridization at this time point, suggesting
that the observed staining pattern was not attributable to non-
specific hybridization. At later developmental points, the pattern
appeared unaltered, but the expression level progressively reduced
and was barely detectable by 96 hpf. In the adult, both tor1_tv1
and tor1_tv2 were detected by RT-PCR in several tissues including
brain, foregut, hindgut, muscle, and gonad (figure 6B). Relative to
bactin1, expression of both isoforms was lower in brain and muscle
compared to gut and gonad, suggesting reduced expression of tor1
in post-mitotic tissues. In addition, the relative expression of the
two transcripts differed between tissues. For example, tor1_tv1 was
more abundant in foregut, whereas tor1_tv2 was expressed more
strongly in the hindgut. These data suggest that expression of the
two transcripts is regulated independently by distinct cis-regulatory
elements, as might be predicted from their separate promoters.
Zebrafish Torsin1 Proteins and their Subcellular
Localization
The amino termini of Torsin1a and Torsin1b, encoded by
exons 1A and 1B, are divergent. However, both are predicted to
contain a cleavable ER retention signal, followed by an alpha-
helical domain and both Torsin1a and Torsin1b are 336 amino
acids in length. Alignment of zebrafish Torsin1a and Torsin1b
with human TorsinA and TorsinB revealed conservation of key
functional domains, including consensus sequences for the ATP-
binding Walker A domain, the ATP-hydrolysis Walker B domain,
and the Sensor 1, and Sensor 2 domains (figure 7A). Both
zebrafish isoforms are 59% identical and 78% similar to TorsinA
and 57% identical and 77% similar to TorsinB. Human TorsinA
and TorsinB share 66% identity and 77% similarity. The highest
degree of divergence between zebrafish Torsin1 and human
TorsinA was observed within the amino terminus (figure 7B).
Similarly, maximal divergence between Human TorsinA and
TorsinB was also within the amino terminus.
The DYT1 dystonia mutation causes deletion of one glutamate
residue from an EE motif in the carboxyl terminal of TorsinA.
Although the pathophysiological properties of this mutation are
yet to be fully elucidated, one striking property of the mutant is
relocalization of the protein from the endoplasmic reticulum to the
nuclear envelope [12]. The homologous region in zebrafish
Torsin1 contains the amino acids HD (figure 7A), precluding
mutagenesis studies to determine whether the zebrafish protein
undergoes similar relocalization following introduction of the same
mutation. However, redistribution of human TorsinA to the
nuclear envelope is also observed when null mutations are
introduced into the Walker B ATP hydrolysis domain of TorsinA
[9,12]. To investigate whether the subcellular localization of
Torsin1a and Torsin1b can be altered by similar mutations, we
constructed zebrafish Torsin1-eGFP fusion proteins and examined
their localization in transfected cells. Both Torsin1a and Torsin1b
isoforms primarily localized to the cytosol (figure 8A, B) in the
mouse dopaminergic MN9D cell line. In a small percentage of
cells, Torsin1-eGFP fusion protein could also be detected at the
nuclear envelope (figure 8C). This distribution pattern is consistent
with the diffuse intracellular localization observed with human
TorsinA [11]. Next, we examined whether mutations in the
conserved ATP binding (Walker A) and ATP hydrolysis domains
(Walker B) of Torsin1 altered the cellular redistribution of Torsin1.
Similar to human TorsinA, mutation (K114T) of the ATP binding
domain of Torsin1 [13,56] did not alter the cytoplasmic
localization of the Torsin1-eGFP fusion proteins (figure 8A, C).
However, Torsin1-eGFP[K114T] was not detected in the nuclear
envelope of transfected cells, suggesting that ATP binding is
Figure 1. Identification of zebrafish Torsins. Human TorsinA was used as a probe to interrogate the NCBI zebrafish RefSeq and non RefSeq RNA
databases by TBLASTN. Eight different zebrafish mRNA and predicted mRNA sequences with homology to TorsinA were translated and aligned with
Torsins from C. elegans, D. melanogaster, Xenopus, Chicken, and Human. A dendrogram was constructed to illustrate the inferred evolutionary
relationships between Torsin family proteins from different species.
doi:10.1371/journal.pone.0045175.g001
Figure 2. Zebrafish tor1 is expressed as two different transcript variants. The two zebrafish transcripts most closely related to human TOR1A
were found to be transcribed from a single gene by inclusion of alternative 59 exons. tor1 transcript variants 1 and 2 encode Torsin1 isoforms a and b,
which differ at their N termini. The two transcripts are depicted above the genomic sequence. The splice boundaries targeted by morpholino
oligonucleotides in figure 10 are labeled ‘MO’.
doi:10.1371/journal.pone.0045175.g002
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required for Torsin1 to enter the nuclear envelope. Conversely,
mutation (E177Q) of the ATP hydrolysis domain [13,56] caused
accumulation of Torsin1-GFP in the nuclear envelope (figure 8B,
C). These results show that (i) similar to human TorsinA, zebrafish
Torsin1 can enter the nuclear envelope; and (ii) mutation of the
ATP hydrolysis domain of Torsin1 results in its sequestration in
this location. Zebrafish Torsin1 proteins thus share key aspects of
dynamic cellular localization with human TorsinA, and this
depends on at least some of the same functional domains. This
suggests that zebrafish Torsin1 and human TorsinA may share a
common set of interacting proteins.
Zebrafish Torsin1 Proteins – glycosylation and Expression
in Adult Brain
In order to better characterize Torsin1, we next developed a
polyclonal antibody against a peptide sequence near the carboxyl
terminal, which is divergent between Torsin1 and other zebrafish
Torsins (figure 9A). Polyclonal antisera to this antigen were raised
in rabbits, and affinity-purified against the peptide. The purified
antibody was initially tested by probing western blots of protein
lysates from HEK293 cells, which were transfected with a
construct expressing tor1_tv2 under the CMV immediate-early
promoter, or empty vector as a negative control (figure 9B). A
single immunoreactive species of 35 kDa was detected in cells
expressing tor1_tv2, whereas no immunoreactive proteins were
present in cells transfected with empty vector. This demonstrates
that the antibody can recognize Torsin1 expressed in cultured
cells. Next, we analyzed adult zebrafish brain lysate by western
blot (figure 9C). Two bands were detected with apparent
molecular weights of 47 kDa and 45kDa. Detection of both bands
was prevented by pre-incubation of the antibody with the cognate
peptide, and neither band was present when blots were probed
with pre-immune serum. These data confirm that the 47 kDa and
45 kDa species contain the cognate peptide sequence, and
therefore most likely represent Torsin1. tor1 is expressed at low
levels in embryos, and we did not detect convincing Torsin1-
immunoreactive signal during early development. Consequently
we were not able to further confirm specificity of the antibody for
Torsin1 in vivo by showing loss of immunoreactive signal after
morpholino knockdown of tor1 expression (see discussion). The
apparent molecular weight of Torsin1 differed between cultured
cells and the zebrafish brain in vivo. It is known that Torsins are
Figure 3. Syntenic relationships of tor1, TOR1A and TOR1B. A: The diagram shows the order and orientation of genes flanking TOR1A and
TOR1B in the human and xenopus genomes, and tor1 in the coelacanth genome. The map is shown to scale; large arrows show the direction of the
telomere. TOR1A, TOR1B and tor1 are colored black. The flanking genes are colored green (USP20), red (FNBP1), blue (C9orf78), orange (PTGES) and
lilac (PRRX2). Orthologous genes are connected by solid lines. B: The diagram shows the order and orientation of genes flanking tor1 in the zebrafish,
fugu, stickleback, and tetraodon genomes. The color scheme is identical to panel A; additional flanking genes are colored as follows: dark grey -
conserved chromosomal positions in all four fish species; light grey - conserved chromosomal positions in two or three fish species; white -
chromosomal position not conserved.
doi:10.1371/journal.pone.0045175.g003
Zebrafish tor1
PLOS ONE | www.plosone.org 7 September 2012 | Volume 7 | Issue 9 | e45175
Figure 4. tor1 promoters and transcripts. A: Zebrafish brain total RNA was treated with tobacco acid pyrophosphatase (TAP+; lanes 2 and 4) or
untreated (TAP2; lanes 3 and 5) prior to RACE adapter ligation and reverse transcription. tor1 was amplified by 59RACE using a tor1 exon 2 reverse
primer and a RACE adapter primer (lanes 2 and 3) or by RT-PCR using tor1 primers (lanes 4 and 5). B, C: The transcriptional start sites of tor1_tv1 (B)
and tor1_tv2 (C) were determined by comparing the genomic sequence with sequences of the 59 RACE products shown in panel A. The
transcriptional start sites are shown underlined with arrows; bases are numbered such that +1 represents the first nucleotide of the most 59
transcriptional start site. The open reading frames of exons 1A and 1B and their 39 splice sites are shown. The consensus ANNAUG translational
initiation signals are indicated in bold and underlined; non-consensus AUG sequences in the 59UTR of tor1_tv2 are underlined. D: 39RACE was
employed to determine the 39 terminus of the transcript. The polyadenylation signal within exon 5 is underlined in bold. The position of the poly(A)
tail in the mRNA is indicated. E: Brain total RNA was separated electrophoretically and the resulting northern blot was probed using a cRNA probe to
tor1. The positions of molecular size standards and the 28S and 18S rRNA bands are shown.
doi:10.1371/journal.pone.0045175.g004
Figure 5. Genomic organization of zebrafish tor1 compared with human TOR1A. The splice acceptor and donor sequences for each intron/
exon boundary of the zebrafish tor1 gene are shown, alongside the length of each exon and the phase of each splice boundary. The exon length and
phase of human TOR1A are shown for comparison.
doi:10.1371/journal.pone.0045175.g005
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Figure 6. tor1 is expressed ubiquitously. A: RNA in situ hybridization was employed to detect the tor1 transcript during development.
Hybridized probe was detected using a histochemical reaction with a blue/purple product. The photomicrograph shows embryos at 12 hpf; the
upper of the pair was hybridized with a tor1 antisense probe and the lower with a tor1 sense control probe. B: Reverse transcriptase PCR was
employed to detect tor1_tv1 (upper panel) or tor1_tv2 (middle panel) mRNA in brain, foregut, hindgut, muscle, and gonads of adult zebrafish. Total
RNA was treated with reverse transcriptase (RT+); controls lacking reverse transcriptase (RT-) excluded amplification of genomic DNA sequences.
bactin1 was amplified as a ubiquitously expressed control mRNA (lower panel).
doi:10.1371/journal.pone.0045175.g006
Figure 7. Zebrafish and human Torsin1 family proteins are highly homologous. A: The AlignX implementation of the ClustalW algorithm
was used to align the amino acid sequences of zebrafish Torsin1a and 1b, and human TorsinA and TorsinB. The Walker A (ATP binding), Walker B (ATP
hydrolysis), Sensor 1 and Sensor 2 domains are labeled. The position of the glutamic acid deletion associated with DYT1 dystonia is indicated.
Identical and similar amino acids at each position of the alignment are colored as shown. B: Zebrafish Torsin1a is depicted schematically showing the
functional domains discussed in the text. The graph below shows similarity between zebrafish Torsin1a and human TorsinA at each position of a
sliding 15-amino acid window of comparison, corresponding to the schematic drawing of Torsin1 above (0 =no homology, 1 = identity). Key: ER,
endoplasmic reticulum signal; HD, hydrophobic domain.
doi:10.1371/journal.pone.0045175.g007
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subject to post-translational modifications, including signal peptide
cleavage and N-glycosylation [11,57]. Pre-incubation of brain
lysate with peptide:N-glycosidase F (PNGase F), an amidase that
cleaves between asparagine and the innermost N-acetyl-glucos-
amine (GlcNAc) residue of the oligosaccharide chain of N-linked
glycoproteins, altered the electrophoretic mobility of the Torsin1-
immunoreactive species, which migrated at 36–38 kDa following
PNGaseF treatment (figure 9D). This mobility shift demonstrates
the presence of N-linked carbohydrate chains totaling approxi-
mately 9 kDa. The consensus ‘sequon’ or target sequence for N-
glycosylation is N-X-S or N-X-T, where X is any residue except
for proline. There are two predicted N-glycosylation sites in
Torsin1, at residues 63 and 164 (figure 9E). The lower apparent
molecular weight observed in cultured cells suggests that post-
translational processing of Torsin1 differs between transformed
human kidney cells and the zebrafish brain in vivo.
Sections from adult zebrafish CNS were labeled with Torsin1
antibody. Immunoreactive signal was seen in multiple different
brain regions and was abolished by pre-incubation of the antibody
with the cognate peptide (figure 9F), indicating that the tissue
epitope recognized by the antibody is shared by the peptide, and is
therefore likely to represent Torsin1. Torsin1-related immunore-
activity was abundant in grey matter regions, such as the optic
tectum, cerebellum, brainstem nuclei and central grey matter of
the spinal cord (figure 9F–K). In contrast, white matter tracts,
including the optic nerves and tracts, the medial longitudinal
fasciculus and long descending tracts of the spinal cord, did not
show Torsin1-related immunoreactivity (figure 9G, K). Cytoplas-
mic labeling was apparent in many neurons of the brainstem, optic
tectum and diencephalon (figure 9H). Torsin1-related immunore-
activity was also abundant in the neuropil and some neurons
showed punctate staining around the perimeter of their cytoplasm,
raising the possibility that Torsin1 may also be expressed in nerve
terminals (figure 9J). These data suggest that Torsin1 is expressed
in the cell body, dendrites and possibly also terminals of neurons in
multiple CNS regions, but is not expressed in myelinated fibers.
Physiological Expression of tor1 is not Required for Early
Development of Motor Circuits
To determine the function of tor1 during larval development, we
targeted its expression by using morpholino antisense oligonucle-
otides (MOs). We opted to use splice site MOs to inhibit pre-
mRNA processing, because knockdown could be verified readily
by RT-PCR. Initial studies showed that a combination of two
MOs targeting the exon2/intron2 and exon3/intron3 splice donor
consensus sequences caused both exons 2 and 3 to be excluded
from the transcript (figure 10A). This resulted in a frame shift and
formation of a premature stop codon, which abrogated expression
of the Walker B domain and both Sensor domains (figure 10B).
This combination of MOs efficiently disrupted expression of tor1
mRNA up to up to 4 days post fertilization (dpf); densitometry
estimated that less than 10% of the tor1 RT-PCR product at
24 hpf was derived from the full-length transcript (Figure 10C). To
exclude phenotypes attributable to adverse effects from microin-
jection, and non-specific toxicity of MOs, we compared tor1
knockdown zebrafish with wild-type animals, and with animals
injected with control non-targeting MO.
There were no differences between uninjected, control MO
injected, and tor1 MO injected embryos in any of the parameters
we measured. For clarity, data are shown for WT and tor1
knockdown animals only. Zebrafish from all three experimental
groups showed normal morphological development through day 7
(not shown). We next evaluated development of dopaminergic
neurons, because the function of the dopamine system is disrupted
in some patients with dystonia [17]. Whole mount RNA in situ
hybridization was employed to label developing dopaminergic
neurons using a probe specific to the slc6a3 transcript encoding the
dopamine transporter, which is expressed in dopamine neurons
[58,59]. We did not observe any differences between wild type
larvae and tor1 morphant larvae in the position of dopaminergic
neurons or in the intensity of slc6a3 expression at 48 hpf or 72 hpf
(figure 10D and data not shown). The total number of
diencephalic slc6a3+ neurons was determined in each population
of zebrafish; knockdown of tor1 did not affect the number of
dopamine neurons at 48 or 72 hpf (figure 10E and data not
Figure 8. ATP-binding and ATP-hydrolysis mutations in Torsin1 alter cellular localization. MN9D cells were transfected with expression
plasmids encoding either (A) Torsin1a-eGFP or (B) Torsin1b-eGFP fusion proteins. The images show single confocal planes through transfected cells
demonstrating GFP fusion protein localization (green, left column) relative to the nucleus (DAPI counterstain, blue, center column). For each panel,
the top row of images shows wild type Torsin1, the middle row of images shows a Torsin1[K114T] mutant, which disrupts the Walker A (ATP-binding)
domain, and the bottom row shows a Torsin1[E177Q] mutant, which disrupts the Walker B (ATP hydrolysis) domain. (C) Four independent samples for
each construct were evaluated for nuclear envelope localization of the fusion protein. The graphs show the mean % cells with nuclear envelope
localization (100–200 cells were scored for each construct; error bars show standard error; ***P,0.0001, *p,0.05 versus WT, heteroscedastic 2-tailed
T-test with Bonferroni correction).
doi:10.1371/journal.pone.0045175.g008
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shown). We conclude that, similar to murine TOR1A2/2 lines
[22], knockdown of tor1 in zebrafish did not give rise to
abnormalities in the number or position of dopamine neurons
during development.
Finally, we asked whether knockdown of tor1 provoked
abnormalities of motor function by employing a previously
described assay [50,51] to quantify spontaneous propulsive
movements in uninjected larvae, control MO injected larvae,
and Torsin1 morphant larvae. Compared with controls, larvae
lacking physiological expression levels of Torsin1 did not show
statistically significant differences in mean velocity, percent time
moving, active velocity, mean duration of movement bursts, or
mean rest duration between movements at 4–6 dpf (figures 10F-J
show data at 5 dpf). At earlier developmental time points before
4 dpf, when tor1 knockdown was most prominent, larval propul-
sive movements are infrequent and variable, making it difficult to
detect differences between experimental groups [51]. To evaluate
zebrafish between 1–4 dpf, we employed a second method that
determines changes in pixel grayscale values from frame to frame
of a video stream, rather than detecting displacement of the larval
Figure 9. Torsin1 is a neuronal glycoprotein. A: The peptide sequence used to raise polyclonal antibodies to zebrafish Torsin1 is shown
underlined in bold. An alignment between Torsin1 and the homologous regions of other zebrafish Torsin-like proteins is shown to illustrate the lack
of potentially cross-reacting sequences in other Torsins. Amino acids that are identical to Torsin1 at each position are highlighted in yellow. B: HEK
cells were transfected with a plasmid encoding Torsin1b (lane 1) or with empty vector (lane 2). A western blot made with lysates from transfected
cells was probed with affinity-purified Torsin1 antibody. The blot was then re-probed with an antibody to b-actin as a control for equal protein
loading (lower panel). C: Identical samples of zebrafish whole brain lysate were resolved by SDS-PAGE in adjacent lanes of a gel and the resulting
western blot was divided into strips each containing a single lane. The strips were probed with either affinity-purified Torsin1 antibody (lane 1),
affinity-purified Torsin1 antibody pre-incubated with the peptide immunogen shown in panel A (lane 2), or pre-immune serum (lane 3). The blots
were then re-probed with an antibody to b-actin as a control for equal protein loading (lower panel). D: Whole brain lysate was either treated with
PNGase F (lane 2) to remove N-linked carbohydrate moieties, or mock treated without addition of PNGase F (lane 1), prior to SDS-PAGE and
immunoblotting with Torsin1 antibody. E: Schematic representation of Torsin1 showing the positions of the consensus N-glycosylation sites. F–K:
Adult zebrafish CNS sections were labeled with Torsin1 antibody; immunoreactive structures were revealed by chromogenic histochemistry with a
red reaction product. Sections were counterstained with Mayer’s hematoxylin so that nuclei appear blue. (F) Parasagittal sections of the whole
zebrafish brain are shown labeled with Torsin1 antibody. In the lower panel, the antibody was pre-incubated with the peptide immunogen. (G) Optic
tectum. Key: SM, stratum marginale; SO, stratum opticum; SFGS, stratum fibrosum griseum superficiale; SGC, stratum griseum centrale; SAC, stratum
album central; SPV, stratum periventriculare. (H) Periventricular layer of optic tectum (upper panel) and medulla oblongata (lower image), showing
cytoplasmic Torsin1 expression in neurons (arrowheads). (J) Thalamus (upper panel) and cerebellum (lower panel) showing Torsin1-related
immunoreactivity in neuropil; arrowhead in upper panel shows a neuron surrounded by punctate Torsin1 immunoreactivity that may be present in
nerve terminals. (K) Spinal cord at low magnification (upper panel) and high magnification (lower panel) showing robust Torsin1 immunoreactive
signal in gray matter, but absence of Torsin1 in white matter. The arrowhead in the lower panel shows the myelin sheath surrounding the Mauthner
axon (MA).
doi:10.1371/journal.pone.0045175.g009
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centroid. The pixel quantification method is sensitive to both
propulsive and non-propulsive movements, such as coiling and re-
orientation movements, and consequently has previously allowed
us to detect differences in motor activity between experimental
groups at early developmental points [60]. However, even using
this method, we did not detect differences between the motor
activity of controls and tor1 knockdown animals between 1–4 dpf
(data not shown). Taken together, these findings suggest that wild-
type expression levels of Torsin1 are not required for early
morphological development and function of the motor system.
Discussion
The data presented here suggest that a novel zebrafish gene,
tor1, is a single zebrafish homolog of the mammalian TOR1A and
TOR1B genes. Conservation of sequence and genomic organiza-
tion provide strong evidence that the zebrafish and human genes
share a common ancestor, and we found notable similarities
between the expression patterns of the human and zebrafish
mRNAs, and the domain organization and subcellular localization
of the proteins. There is limited conservation of synteny between
teleost and tetrapod genomes in the immediate vicinity of the tor1
genes, suggesting that substantial genomic reorganizations oc-
curred in this region during evolution. One of the more striking
differences is the presence of adjacent TOR1A and TOR1B genes
Figure 10. Torsin1 is non-essential for early development of the motor system. A: Single-cell zebrafish embryos were microinjected with
morpholino oligonucleotides designed to block splicing of tor1 exons 2 and 3 (see figure 2). At the times indicated between 24 and 120 hours post-
fertilization, RNA was harvested from developing zebrafish and subjected to RT-PCR using primers specific for tor1_tv1 (upper panel) or tor1_tv2
(lower panel). The pictures show ethidium bromide stained agarose gels after the PCR products were resolved by electrophoresis. The positions of
PCR products corresponding to wild-type tor1 mRNA and the transcript lacking exons 2 and 3 are shown. B: A schematic representation is shown of
the predicted protein products produced by transcripts lacking exons 2, 3 or both exons. It is not known if any of these truncated products is stable.
C: The % tor1 RT-PCR product arising from the wild-type, full-length mRNA at each time point following MO injection was estimated by densitometry.
D: Whole mount RNA in situ hybridization was carried out using a cRNA probe for slc6a3 (‘dat’) to localize dopaminergic neurons. Representative
dorsal views are shown of the brains of an uninjected control embryo (left panel) and an embryo lacking Torsin1 (right panel) at 48 hours post-
fertilization. The inset panels show representative lateral views. Developing dopaminergic neurons in the diencephalon are indicated by arrowheads.
E: The total number of slc6a3+ cells in the diencephalon was counted in zebrafish lacking Torsin1 and control zebrafish at 48 hpf. Graphs show mean
number of cells, error bars show standard error. F–J: Spontaneous movements of uninjected wild-type zebrafish (n = 16) and zebrafish injected with
MO targeting tor1 (n = 19) were recorded at 5 dpf in 96-well plates using a video camera. Recordings were analyzed to determine: (F) mean velocity
(total displacement/total time of recording); (G) active velocity (displacement/time spent moving); (H) % time active; (I) mean duration of active
episodes; and (J) mean duration of rest episodes. For each graph, values for each individual larva are shown as small circles and the mean for the
group shown as a filled square. Error bars shown standard error.
doi:10.1371/journal.pone.0045175.g010
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in tetrapods, whereas the genomes of zebrafish, fugu, stickleback,
tetraodon and coelacanth all contain a single tor1 gene. These data
strongly suggest that an ancestral tor1 locus was duplicated during
the fin-to-limb transition, resulting in the occurrence of distinct
TOR1A and TOR1B genes before the emergence of amphibious
tetrapods. Whether the separate TOR1A and TOR1B genes have
divergent functions remains to be determined; TorsinA and
TorsinB show complementary expression patterns [61] and it is
possible that they mediate similar cellular functions in different
groups of cells, similar to the numerous other paralogous proteins
with distinct expression patterns that show redundant functions
[62]. In support of the possibility that TorsinA and TorsinB have
redundant functions, there is evidence that TorsinB may partially
compensate for the functional effects of mutations in TorsinA:
morphological abnormalities of the nuclear envelope in fibroblasts
derived from DE/DE knock-in mice were exacerbated by loss of
TorsinB [61]. Consequently, it is possible that the single tor1 gene
in zebrafish will prove advantageous for determining the role of
Torsin1 in neurons, since loss-of-function phenotypes might not be
mitigated by compensatory functions provided by closely related
proteins. Similar to the relationship between human TorsinA and
TorsinB, zebrafish Torsin 1a and Torsin 1b are most divergent
within the N-terminal region. It is possible that discrete functions
of TorsinA and TorsinB are distributed between the two isoforms
encoded by the tor1 gene in zebrafish. Compatible with this idea,
the expression pattern of tor1 showed similarities to both TOR1A
and TOR1B. The relatively weak expression of both tor1_tv1 and
tor1_tv2 in the brain, compared to gut and gonads resembles the
expression of mammalian TOR1B, which is more abundantly
expressed in somatic cells than neurons. Conversely, Torsin1-
related immunoreactivity in the zebrafish nervous system ap-
peared to closely resemble the expression pattern of TorsinA in the
mammalian nervous system, with prominent localization in the
cell body and processes of neurons and absence from white matter
tracts. The development of isoform-specific antibodies to zebrafish
Torsin1a and Torsin1b will allow clarification of whether the
expression patterns of these two proteins are complementary and
similar to mammalian TorsinA and TorsinB.
In order to characterize the zebrafish Torsin1 protein, we
developed a novel antibody directed towards its C-terminus. We
showed that: (i) the antibody recognizes a protein produced by
expression of cDNA encoding tor1 in cultured cells; and (ii) pre-
incubation of the antibody with its cognate peptide prevented it
from detecting epitopes on either western blot or tissue sections.
These controls support the conclusion that the antibody specifi-
cally detected Torsin1 in zebrafish brain. However, loss of
immunoreactive signal in genetic knockout tissue is generally
considered a ‘gold standard’ for proving antibody specificity [63];
in this case, the absence of clearly demonstrable Torsin1
immunoreactivity during early development precluded confirma-
tion of specificity by MO-mediated knockdown of the tor1
transcript. Formal proof that the antibody specifically detects
Torsin1 in the zebrafish brain therefore awaits the development of
stable tor12/2 lines. Nonetheless, the availability of this antibody
allowed some initial conclusions to be drawn about the nature of
Torsin1: it is expressed as two species in CNS, a major 45 kDa
form and a minor 47 kDa form; both species are heavily N-
glycosylated, showing loss of 9 kDa carbohydrate after deglycosy-
lation; and the protein localizes to neuronal somatic cytoplasm and
possibly also nerve terminals within the neuropil, but was not
detected within axons. These properties are similar to those
previously reported for human TorsinA, and are compatible with
an endoplasmic reticulum subcellular localization in neurons. The
origin of the two protein species is unclear; the predicted
molecular weights of Torsin1a and Torsin1b are similar
(38.2 kDa and 38.4 kDa, respectively) and approximately the size
of the major protein isoform found after deglycosylation. It is
possible that different post-translational modifications are respon-
sible for the two forms, or that signal peptide cleavage is directed
to a different site in the nascent protein by each of the unique N-
termini.
Relocalization of TorsinA from the endoplasmic reticulum to
the nuclear envelope is a hallmark of the dystonia-associated DE
mutation [12]. This relocalization can also be induced by
mutations in the ATP-hydrolysis domain of TorsinA [9,12].
Although we were not able to introduce the DE mutation into
Torsin1, because of limited sequence conservation with respect to
the human protein in this region of the C-terminus, we have
demonstrated that zebrafish Torsin1 can be made to accumulate
in the nuclear envelope by the introduction of a putative ATP-
hydrolysis null mutation in the Walker B domain. Interestingly,
this relocalization was observed in a heterologous murine cell line.
Trafficking of Torsins between nuclear envelope and endoplasmic
reticulum is thought to depend on their interactions with specific
substrates and with other Torsin molecules in hexameric
complexes. This raises the possibilities that the zebrafish protein
may interact with: (i) one or more mammalian nuclear envelope
proteins, possibly some of the same proteins that interact with
endogenous mammalian Torsins; or (ii) endogenous mammalian
TorsinA to form complexes. These possibilities are not mutually
exclusive and both are equally compatible with the data presented.
For example, even if zebrafish Torsin1 did not recognize murine
nuclear envelope substrates, disruption of its ATPase domain may
have prevented a Torsin1/TorsinA heterohexamer from disen-
gaging from a substrate. These data show an intriguing degree of
functional interaction between the heterologous proteins and
imply that at least some of the cellular roles may be phylogenet-
ically conserved. It will be of interest to determine whether human
TorsinA behaves similarly in zebrafish cells, since this will have
significant implications for generating a zebrafish model of DYT1
dystonia based on transgenic expression of human TorsinA[DE].
Zebrafish homologues of many of the human proteins known to
interact with TorsinA have been described, and we have identified
candidates for others by database searching (Table S1). It will be of
considerable interest to determine whether these proteins interact
with Torsin1, suggesting phylogenetic conservation of biochemical
properties and functions.
We did not identify any morphological or neurobehavioral
abnormalities resulting from reduced Torsin1 expression early in
development, although the use of RNA in situ hybridization to
label dopamine neurons does not allow examination of neuronal
morphology and so the data do not exclude, for example,
abnormalities of dendritic branching. The absence of prominent
phenotypes in morphant larvae could be attributable to incom-
plete knockdown of Torsin1 (figure 10A, C) or compensatory
functions provided by other Torsin proteins. However, these data
are also consistent with findings in murine TOR1A2/2 lines, in
which the first observed phenotypic abnormality was perinatal
lethality due to lack of feeding [22]. In zebrafish, the analogous
developmental point occurs after 5 dpf, when patterning of the
nervous system is nearly complete and larvae begin actively
pursuing food. Unfortunately, by this time point, the expression of
both tor1 transcripts had largely recovered from transient MO-
mediated knockdown (figure 10A, C); consequently it remains
unclear whether loss of tor1 in zebrafish at later developmental
points would provoke similar abnormalities to those observed in
mice lacking TorsinA. DYT1 dystonia patients usually first show
symptoms during late childhood or adolescence. Consequently, it
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is expected that critical CNS functions of TorsinA, of relevance to
the pathogenesis of dystonia, could occur much later during
development. In order to address these possibilities and to
elucidate the role of Torsin1 during later development, it will be
necessary to develop stable tor12/2 lines. This would not only
allow unambiguous evaluation of Torsin1 functions at later time
points, but will also facilitate validation of Torsin1 antibodies for
further biochemical studies.
In conclusion, our data suggest that the zebrafish may provide a
powerful model system to study the neuronal functions of Torsin1
in vivo, and an opportunity to elucidate the molecular evolution of
Torsins. Our work provides essential background for future studies
on tor1 gene function and raises the intriguing possibility of
generating a transgenic zebrafish model of DYT1 dystonia, with
potential applications in understanding pathogenesis and devel-
oping novel treatments.
Supporting Information
Table S1 Zebrafish homologs of TorsinA-interacting proteins.
Human proteins known to interact with TorsinA are shown in the
first column and details of their genes shown in the second column.
The third column shows details of the proposed zebrafish
homologues of these genes (references are shown where available;
otherwise, Sager et al this publication). The final column shows the
degree of homology between the human and zebrafish proteins as
% amino acid residues that are identical or homologous between
human and zebrafish.
(PDF)
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